- Home
- LARK vs BDTX Comparison
LARK vs BDTX Comparison
Compare LARK & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LARK
- BDTX
- Stock Information
- Founded
- LARK 1885
- BDTX 2014
- Country
- LARK United States
- BDTX United States
- Employees
- LARK N/A
- BDTX N/A
- Industry
- LARK Major Banks
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LARK Finance
- BDTX Health Care
- Exchange
- LARK Nasdaq
- BDTX Nasdaq
- Market Cap
- LARK 140.8M
- BDTX 144.9M
- IPO Year
- LARK N/A
- BDTX 2020
- Fundamental
- Price
- LARK $24.00
- BDTX $2.20
- Analyst Decision
- LARK
- BDTX Strong Buy
- Analyst Count
- LARK 0
- BDTX 4
- Target Price
- LARK N/A
- BDTX $15.50
- AVG Volume (30 Days)
- LARK 4.4K
- BDTX 1.2M
- Earning Date
- LARK 01-29-2025
- BDTX 03-11-2025
- Dividend Yield
- LARK 3.33%
- BDTX N/A
- EPS Growth
- LARK 14.37
- BDTX N/A
- EPS
- LARK 2.14
- BDTX N/A
- Revenue
- LARK $56,988,000.00
- BDTX N/A
- Revenue This Year
- LARK N/A
- BDTX N/A
- Revenue Next Year
- LARK N/A
- BDTX N/A
- P/E Ratio
- LARK $11.20
- BDTX N/A
- Revenue Growth
- LARK N/A
- BDTX N/A
- 52 Week Low
- LARK $17.05
- BDTX $1.91
- 52 Week High
- LARK $25.25
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- LARK 54.59
- BDTX 46.41
- Support Level
- LARK $23.05
- BDTX $2.02
- Resistance Level
- LARK $24.49
- BDTX $2.33
- Average True Range (ATR)
- LARK 0.58
- BDTX 0.18
- MACD
- LARK -0.06
- BDTX 0.03
- Stochastic Oscillator
- LARK 75.68
- BDTX 38.16
About LARK Landmark Bancorp Inc.
Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The bank is principally engaged in the business of attracting deposits from the general public and using such deposits, together with borrowings and other funds, to originate one-to-four-family residential real estate, construction and land, commercial real estate, commercial, agriculture, municipal and consumer loans. In addition, it also invests in certain investment and mortgage related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.